Skip to main content
Clinical Trials/NCT01591564
NCT01591564
Completed
Not Applicable

Interpersonal Psychotherapy in Youth With Severe Mood Dysregulation-Pilot

Johns Hopkins University1 site in 1 country3 target enrollmentJuly 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Severe Mood Dysregulation
Sponsor
Johns Hopkins University
Enrollment
3
Locations
1
Primary Endpoint
Retention rate
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine the feasibility and acceptability of an utilizing an adapted form (IPT-SMD)of a psychosocial intervention, Interpersonal Psychotherapy for Depressed Adolescents, for youth with severe mood dysregulation (SMD).

The investigators hypothesize that retention rates will be >80%,satisfaction scores will average 6 (high) on a 7 point satisfaction scale, and that youth who receive the IPT-SMD intervention will have overall improvement in SMD symptoms.

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
December 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Leslie Miller, M.D.

Assistant Professor

Johns Hopkins University

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects, ages 13 to 17 years, who meet criteria for severe mood dysregulation as defined by NIMH criteria.
  • Subject has an estimated IQ \>70 on the Kaufman Brief Intelligence Test (KBIT-2)
  • Subjects will have continuously resided with a legal guardian who has known the adolescent well for at least one year before study entry and is legally able to sign the consent form.
  • Participants must be on the same dose of any prescribed medication for 4 weeks prior to randomization.
  • Children's Global Assessment Scale (CGAS) ≤ 60

Exclusion Criteria

  • Subject poses a significant risk for dangerousness to self or others. Risk will be determined by clinical history, clinical diagnostic interview and KSADS-PL interview of parent and patient by clinician.
  • Subject suffers from a concomitant medical or psychiatric co-morbidity that makes this study protocol inadvisable (either the treatment is contraindicated or the disorder is not the primary focus of treatment).
  • Subject meets DSM-IV criteria for current alcohol or substance dependence or current use (defined as the past 4 weeks).
  • Pregnant females.
  • Primary caretaker does not speak English

Outcomes

Primary Outcomes

Retention rate

Time Frame: 20 weeks

We are assessing the feasibility and acceptability of IPT-SMD in anticipation of conducting a larger trial.

Secondary Outcomes

  • Clinical Global Impressions Scale CGI-I (SMD)(20 weeks)

Study Sites (1)

Loading locations...

Similar Trials